Incretin-based therapy: renal effects

Glucagon like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors are new classes of hypoglycemic agents with numerous pleiotropic effects. The review summarises data about the influence of GLP-1 analogues and DPP-4 inhibitors on structural and functional changes in diabetic ki...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anton Ivanovich Korbut, Vadim Valerievich Klimontov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/5c2fe686f9b64d1a9647f4b4cad14b69
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!